These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15280869

  • 1. Quinolones in dermatology.
    Sable D, Murakawa GJ.
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract] [Full Text] [Related]

  • 2. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
    Medders WM, Wooley RE, Gibbs PS, Shotts EB, Brown J.
    Avian Dis; 1998 Jul; 42(1):146-53. PubMed ID: 9533092
    [Abstract] [Full Text] [Related]

  • 3. Initial clinical experience with clinafloxacin in the treatment of serious infections.
    Tack KJ, McGuire NM, Eiseman IA.
    Drugs; 1995 Jul; 49 Suppl 2():488-91. PubMed ID: 8549411
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic contribution of the new quinolones].
    Wolff M.
    Rev Prat; 1987 Apr 11; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone-resistant Salmonella Paratyphi A.
    Adachi T, Sagara H, Hirose K, Watanabe H.
    Emerg Infect Dis; 2005 Jan 11; 11(1):172-4. PubMed ID: 15714664
    [No Abstract] [Full Text] [Related]

  • 6. Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.
    Radostits OM.
    Int J Infect Dis; 2004 May 11; 8(3):187-9; author reply 190-2. PubMed ID: 15109595
    [No Abstract] [Full Text] [Related]

  • 7. Resistance of shigella to nalidixic acid & fluorinated quinolones.
    Thirunarayanan MA, Jesudason MV, John TJ.
    Indian J Med Res; 1993 Nov 11; 97():239-41. PubMed ID: 8144205
    [Abstract] [Full Text] [Related]

  • 8. The rapid development of fluoroquinolone resistance in M. tuberculosis.
    Ginsburg AS, Woolwine SC, Hooper N, Benjamin WH, Bishai WR, Dorman SE, Sterling TR.
    N Engl J Med; 2003 Nov 13; 349(20):1977-8. PubMed ID: 14614180
    [No Abstract] [Full Text] [Related]

  • 9. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G, Pinsi G, Pirali F, Colombrita D, Foresti I, Peroni L, Turano A.
    Drugs Exp Clin Res; 1989 Nov 13; 15(1):11-5. PubMed ID: 2743869
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses.
    Epstein K, Cohen N, Boothe D, Nieuwoudt C, Chandler J.
    Vet Ther; 2004 Nov 13; 5(2):155-67. PubMed ID: 15468012
    [Abstract] [Full Text] [Related]

  • 11. [The rational use of fluoroquinolones].
    Zhang Y.
    Zhonghua Nei Ke Za Zhi; 1999 Jan 13; 38(1):7-8. PubMed ID: 12795261
    [No Abstract] [Full Text] [Related]

  • 12. [The future of quinolones].
    Gomis M, Ledesma F.
    Enferm Infecc Microbiol Clin; 1996 Oct 13; 14(8):463-5. PubMed ID: 9011201
    [No Abstract] [Full Text] [Related]

  • 13. Enteric fever treatment failures: a global concern.
    Chandel DS, Chaudhry R.
    Emerg Infect Dis; 2001 Oct 13; 7(4):762-3. PubMed ID: 11585550
    [No Abstract] [Full Text] [Related]

  • 14. Quinolones in 2005: an update.
    Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM.
    Clin Microbiol Infect; 2005 Apr 13; 11(4):256-80. PubMed ID: 15760423
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility pattern of bacterial isolates to lomefloxacin.
    Lalitha MK, Nisha AK, Bhattacharya SS, Ramamoorthy U, Lal HM.
    Indian J Med Res; 1990 May 13; 91():182-4. PubMed ID: 2397938
    [Abstract] [Full Text] [Related]

  • 16. Fluoroquinolone resistance in Salmonella Typhi.
    Cooke FJ, Wain J, Threlfall EJ.
    BMJ; 2006 Aug 12; 333(7563):353-4. PubMed ID: 16902221
    [No Abstract] [Full Text] [Related]

  • 17. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the mid-west region of the Republic of Ireland.
    Gorman R, Adley CC.
    J Antimicrob Chemother; 2003 Apr 12; 51(4):1047-9. PubMed ID: 12654768
    [No Abstract] [Full Text] [Related]

  • 18. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan 12; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 19. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun 12; 34(872):58-60. PubMed ID: 1317502
    [No Abstract] [Full Text] [Related]

  • 20. The newer fluoroquinolones.
    O'Donnell JA, Gelone SP.
    Infect Dis Clin North Am; 2004 Sep 12; 18(3):691-716, x. PubMed ID: 15308282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.